June 19, 2019 – Milford, MA-based life science executive search firm Prestige Scientific recently opened its first European office in Amsterdam and appointed Brandan Sweeney as director of the new location. The expansion to Amsterdam is largely in response to the European Medicines Agency’s recent relocation there, said the firm.
Mr. Sweeney is charged with leading the expansion of the regulatory affairs practice in Western Europe. His main focus will be regulatory affairs clinical strategy, regulatory affairs CMC, regulatory affairs operations and regulatory affairs post market with research-based life science companies.
Prior to joining Prestige Scientific, Mr. Sweeney spent 15 years as vice president of regulatory affairs, recruiting for U.S.-based regulatory affairs national search firm Dennis Partners. He was also with Boston-based pharmaceutical company ImmunoGen in a human resources function for six years. Mr. Sweeney has been based in Western Europe since last year.
“Brandan’s considerable knowledge of the regulatory challenges our clients face in the life science industry, paired with his global experience in identifying top regulatory talent, will be tremendous assets in our expansion to the Western European markets,” said Stephen Provost, CPC of Prestige Scientific. “We look forward to expanding our European presence, with the addition of Brandan, and giving our clients the same high-quality results they’ve come to expect during the last 17 years.”
“My dedication and enthusiasm has allowed me to build and maintain an outstanding network of candidate and client relationships,” said Mr. Sweeney. “My candidate community is built on trust and transparency and a successful end-result.”
Closing the Deal with Candidates in the Life Sciences Sector
The competitive landscape of the life sciences industry is transforming recruiting. “Growing pressure to rapidly advance scientific discovery and expand market share is making the competition to attract top talent as fierce as ever.”
Prestige Scientific advises clients on recruiting impactful leaders with proven abilities to increase revenue, decrease expenses and mitigate business risk in the drug development process. The firm provides clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. On average, the firm’s searches are completed in 59 days, with the eventual hire presented to the client by the ninth day of the search, and with a success rate of 99.7 percent.
Persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies as they try to navigate a new world of work, according to Deloitte’s global sector outlook report on life sciences. This will require a dramatic change in strategies for leadership, talent and human resources. What’s more, the global life sciences sector in the midst of a turbulent transformation, making the need for innovative leaders more important than ever.
“Our sector has changed beyond anyone’s expectations over the last two decades,” said Bianca Coulter, CEO of Coulter Partners. “We need to understand the appetites and needs of the major multinationals. This requires reach into all corners of the market. While our office network is growing, the key has been to have multilingual, multi-market experienced and connected researchers and consultants. Our team speaks many languages and has worked in all major bio-pharma markets and is organized as one P&L, to ensure collaborative information and experience sharing.”
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Andrew W. Mitchell, Managing Editor – Hunt Scanlon Media